The results of WHO’s Solidarity trial to evaluate the effects of four potential pharmaceutical regimens – among them, remdesivir, hydroxychloroquine and an anti-HIV combination drug of lopinavir/ritonavir and interferon – were reported by the Financial Times, which obtained a copy of the report.
Prepare Now Before its too Late
Discover where products are available & compare prices
